PAICON’s recent visit to Chile highlighted how meaningful international collaboration can drive progress toward health equity. By connecting with Chilean scientists, entrepreneurs, and leaders, Dr. Manasi A-Ratnaparkhe, CEO and Co-Founder of PAICON, saw firsthand the power of partnerships grounded in diversity and mutual respect. These exchanges underscored the need to combine global insights and local expertise to create medical innovations that truly serve everyone, everywhere.
During her visit, Manasi delivered a keynote and joined a panel at the “Lab to Market” seminar hosted by Pontificia Universidad Católica de Chile. This event brought together pioneering scientists, entrepreneurs, and thought leaders committed to exploring how innovation can better serve communities around the world. Discussions revealed a shared dedication to expanding the reach of scientific advancements so that no population is left behind.
The Chilean innovation community’s strong emphasis on inclusive research was especially striking. Conversations with local experts reinforced a common goal: ensuring that data equity and representative technologies become central to developing solutions for historically underserved populations, resonating deeply with PAICON’s mission to tackle the Remaining84, the vast majority of the world who are still missing from medical data sets today.
Manasi also participated in the Falling Walls Lab Valparaíso, a showcase of bold ideas from Chile’s next generation of innovators. A key moment was engaging with Susanne Fries-Gaier, the German Ambassador to Chile, whose forward-thinking views on international collaboration underscored how essential it is to build partnerships that cross cultural and national boundaries if we are to truly address health disparities worldwide.
These enriching experiences in Chile made one truth undeniable: health equity cannot be achieved in isolation. The inspiring exchanges highlighted that data diversity and inclusive innovation are not just moral imperatives; but they are practical essentials for creating diagnostics, treatments, and technologies that can benefit people everywhere. By forming robust partnerships across continents, PAICON and our global peers can accelerate the delivery of precision medicine and AI-powered healthcare to communities regardless of their location or socioeconomic status.
We are deeply grateful to the extraordinary Chilean innovators, entrepreneurs, and leaders who welcomed us so warmly. Their passion, generosity, and commitment to shaping a more equitable healthcare future remind us that international collaboration is not only possible; also it is the path forward.